Colorectal cancerEvelien Dekker, Michael B. Wallace, Pieter J. Tanis et al.|The Lancet|2019Cited by 5k
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic CancerChunling Hu, Fergus J. Couch, Steven N. Hart et al.|JAMA|2018Cited by 580
<sup>Non-V600</sup><i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy Jones, Axel Grothey, Lindsay A. Renfro et al.|Journal of Clinical Oncology|2017Cited by 357
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving PracticesMidhun Malla, Aparna R. Parikh, Jonathan M. Loree et al.|Journal of Clinical Oncology|2022Cited by 276
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 studyJohn H. Strickler, Marc Van den Evnde, Christophe Borg et al.|The Lancet Oncology|2023Cited by 244